GenAI refers to algorithms and machine learning models used to create content, including text, audio, images, video, and code.
To be a component of the IoT, the report considers any product, application, or service must be part of a larger solution that comprises these 4 elements:
Objects virtualized and imbued with data measurement capabilities
The ability to grant identities to physical and virtual objects
Interconnections between these objects for monitoring and interaction
The ability to generate real-time insights from data and incorporate them into existing business processes
With increasing connected devices comes exponential growth in data volume, which requires novel means of analysis to achieve goals. GenAI technologies are becoming indispensable in unlocking the complete potential of IoT. Augmenting IoT with rapidly advancing GenAI technologies is crucial to delivering GenAIoT-enabled industry solutions.
GenAI and the IoT are revolutionizing the way we interact with the world around us. GenAI can train and run models directly on edge devices, the endpoints of the IoT network. This edge AI approach not only enhances computational efficiency and data security but also unlocks new possibilities for intelligent devices and sensors that continuously generate diverse data streams.
The report covers the following:
Growth drivers and restraints
GenAI market revenue and statistics
Top GenAI-IoT applications
The telecommunications industry's role in the ecosystem
Profiles of top tech companies in the space
Growth opportunities for market participants
Key Growth Opportunities
Growth Opportunity 1: GenAI for Enhanced IoT Security
Growth Opportunity 2: Enhanced Device Intelligence through GenAI
Growth Opportunity 3: AI-powered Smart Home and Building Solutions
Growth Opportunity 4: IoT-connected Vehicles Powered by GenAI
Growth Opportunity 5: IoT-connected Healthcare Powered by GenAI
Growth Opportunity 6: Multimodal Foundational Models for IoT
Growth Opportunity 7: GenAI for Advanced Telecom Networks
Key Topics Covered:
Technology Overview and Definitions
Overview of GenAI
IoT
Overview of IoT Platforms
IoT Platforms and Software - Market Definitions - Global, 2023
Market Overview
Scope of Analysis
Segmentation
Revenue Forecast
Revenue Share by Segment
GenAI in Business - Deployment and Plans
Implementation Challenges of GenAI Initiatives in Business
GenAI-IoT Convergence (GenAIoT)
GenAI-IoT Convergence
GenAI in IoT Platforms
GenAI-IoT Application - IoT Interfaces
GenAI-IoT Application - Code Generation for IoT
GenAI-IoT Application - Robot Control
The Future of the GenAI-IoT Convergence
Unique Position Enables TSPs to Monetize AIoT Opportunities
About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact: Research and Markets Laura Wood, Senior Manager [email protected]
For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716
Tuya Inc. ("Tuya" or the "Company") , a global leading cloud platform service provider, today announced its unaudited financial results for the first quarter ended March 31, 2024.
First Quarter 2024 Financial Highlights
Total revenue was US61.7...
Zepp Health Corporation ("Zepp" or the "Company") today reported revenues of US$39.8 million; a basic and diluted net loss per share of US$0.06; and a basic and diluted net loss per ADS of US$0.23 for the first quarter ended March 31, 2024;...
Yalla Group Limited ("Yalla" or the "Company") , the largest Middle East and North Africa (MENA)-based online social networking and gaming company, today announced its unaudited financial results for the first quarter ended March 31, 2024.
First...
A paper published in the June edition of the Journal Diabetes demonstrates that C-peptide, a biomarker that indicates the production of insulin, is a validated surrogate endpoint, or predictor of clinical benefit, for clinical trials of...
Karman Space & Defense ("Karman"), a concept-to-production solutions provider for the most complex challenges in our industry, proudly announces the launch of its captivating, newly redesigned website, and bold tagline "Impossible Ends Here."...
Nordson Corporation today reported results for the fiscal second quarter ended April 30, 2024. Sales were $651 million, comparable to the prior year's second quarter sales of $650 million. The second quarter 2024 sales included a favorable...